Terns Pharmaceuticals Overview
Terns Pharmaceuticals Target Price
Analysts' 12-month price predictions for TERN.
Share Price
$3.9
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-12-03 | OppenheimerJay Olson | $20 |  412.8% upside |  |
| 2024-09-16 | BMO CapitalEtzer Darout | $26 | 566.7% upside | |
| 2024-08-21 | Mizuho SecuritiesGraig Suvannavejh | $10 | 156.4% upside | |
| 2024-03-15 | BMO CapitalEtzer Darout | $19 | 387.2% upside | |
| 2022-12-29 | H.C. Wainwright | $7 | 79.5% upside | |
| 2022-12-20 | Goldman Sachs | $14 | 259% upside | |
| 2022-09-27 | Goldman SachsCorinne Jenkins | $9 | 130.8% upside | |